The document lists NGSP certified laboratories by date certified, with their certification type and testing method(s). Laboratories must complete bias testing using specific methods, reagents and calibrators to receive traceability certification from the NGSP. Certification criteria are more stringent for Level I laboratories compared to Level II laboratories and manufacturers. Traceability only applies to fresh blood samples unless otherwise specified.
This document provides an overview of Eurofins Medinet, a central laboratory services provider. It details Eurofins' global network of laboratories and key services, including central laboratory services, bioanalysis, biomarkers, and specialized testing. Eurofins offers a full range of analytical testing services to support pharmaceutical and biotech drug development.
ubio is a biotechnology company that develops affordable, accurate, and accessible diagnostics for human, veterinary, and food applications. Their product portfolio includes rapid tests for infectious diseases, cancer, drugs of abuse, and more. Their rapid tests are membrane-based, one-step immunoassays that provide visual results within 20 minutes without equipment. They also develop diagnostic tests, recombinant proteins, antibodies, and manufacturing equipment.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed, novel chemicals are synthesized and tested for efficacy and safety in animals and test tubes. Results are used to select a drug candidate. In clinical studies, the drug is tested in Phase I-III trials with increasing numbers of patients to test safety, efficacy, and get FDA approval for marketing.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
This document provides an overview of Eurofins Medinet, a central laboratory services provider. It details Eurofins' global network of laboratories and key services, including central laboratory services, bioanalysis, biomarkers, and specialized testing. Eurofins offers a full range of analytical testing services to support pharmaceutical and biotech drug development.
ubio is a biotechnology company that develops affordable, accurate, and accessible diagnostics for human, veterinary, and food applications. Their product portfolio includes rapid tests for infectious diseases, cancer, drugs of abuse, and more. Their rapid tests are membrane-based, one-step immunoassays that provide visual results within 20 minutes without equipment. They also develop diagnostic tests, recombinant proteins, antibodies, and manufacturing equipment.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed, novel chemicals are synthesized and tested for efficacy and safety in animals and test tubes. Results are used to select a drug candidate. In clinical studies, the drug is tested in Phase I-III trials with increasing numbers of patients to test safety, efficacy, and get FDA approval for marketing.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
This document provides a training report on various analytical instruments used in the pharmaceutical industry. It describes the principles, procedures, calibration methods, acceptance criteria and applications of key instruments like pH meter, balance, Karl Fischer titrator, dissolution test apparatus, UV spectroscopy and HPLC. The report was submitted as part of a B.Tech degree in biotechnology from Jayoti Vidyapeeth Women's University. It includes sections on cleaning, calibration and testing the performance of pH meters, balances and other analytical equipment used at Kusum Healthcare Pvt. Ltd., where the author completed their training.
Drug discovery process style 1 powerpoint presentation templatesSlideTeam.net
The document describes the drug discovery process from preclinical studies through clinical trials to approval. In preclinical studies, a research team is formed, objectives are set, and novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical trials, the drug is studied in Phase I-III trials with increasing numbers of patients to test safety, efficacy, and get regulatory approval. The company files an Investigational New Drug application and New Drug Application with the FDA.
Strategies for reducing morbidity and mortality from diabetes through healthสปสช นครสวรรค์
This document summarizes recommendations from the Task Force on Community Preventive Services regarding interventions to reduce morbidity and mortality from diabetes. It finds that disease and case management in healthcare systems are strongly recommended for people with diabetes. It also recommends diabetes self-management education in community settings like community centers for adults, and in the home for children and adolescents with type 1 diabetes. There was insufficient evidence to recommend other settings or for adults with type 2 diabetes in the home. The Task Force conducted systematic reviews of interventions focused on healthcare systems and community-based self-management education.
1. The document reports HIV/AIDS statistics for 2556, including 157,000 people living with HIV/AIDS and 3,276.8 new infections.
2. Treatment guidelines are outlined for different CD4 count levels, including the use of viral load monitoring, second line regimens, and laboratory tests.
3. Barriers and recommendations for improving linkage and retention in care are discussed, such as expanding access across different health coverage schemes and centers of excellence.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
This document contains a resume for Arun Kumar, who is seeking a professionally challenging career that allows him to learn and update his skills. He has over 5 years of experience in analytical chemistry and microbiology. His experience includes chemical and microbiological analysis of water, food, and other samples using standardized testing methods. He also has experience in DNA analysis, PCR, and research related to seed and plant development. He holds an MSc in Biotechnology and a BSc in Biotechnology with first class grades.
1) ADICON is a Chinese clinical laboratory company that was established in 2004 and has expanded to include multiple laboratories across China.
2) The document outlines ADICON's history of growth, capacity in various testing areas, quality standards and accreditations, achievements including research collaborations, and vision for the future.
3) ADICON prides itself on high quality services, maintaining various quality standards and accreditations, and has a goal of becoming the top reference clinical laboratory in China and pursuing an IPO by 2013.
S. Lakshmi Narayanan is an analytical research scientist with over 8 years of experience in method validation, development, and analysis in the pharmaceutical industry. He has expertise in GC, HPLC, UV-Vis spectroscopy, dissolution testing, and water content analysis. Narayanan is knowledgeable in GMP and GLP compliance and has experience managing projects and documenting results. He holds an M.Phil. in chemistry and has worked for several companies conducting routine analysis, method development and validation, process optimization, and documentation.
This document provides information about Microcare Laboratory in Surat, India, including its establishment, services, accreditations, staffing, and performance indicators. Microcare Laboratory was established in 2004 and focuses on microbiological and mycobacteriology testing. It has received several accreditations and memberships. Performance data from 2013 shows it processed over 2,000 samples and achieved contamination rates below 5%. Sensitivity and specificity results from a recent external evaluation were over 88%. The laboratory notifies diagnosed TB patients to the local public health authority.
Ch.Rangaih is seeking a position in an organization with strong vision and mission to enhance growth and development. He has a M.Pharmacy from JSS College of Pharmacy with 79.64% and a B.Pharmacy from Nalanda College of Pharmacy with 76.05%. He has over 2 years of work experience as an Assistant Quality Control Officer and Junior Quality Control Chemist. He is proficient in instrumentation skills like HPLC, UV spectroscopy, dissolution testing and has knowledge of quality control and analysis.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
Innovation decision making new product development preclinical fda formulatio...SlideTeam.net
The drug discovery process involves preclinical and clinical studies. In preclinical studies, a research team is formed and objectives are set. Novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical studies, the drug progresses through Phase I-III trials in healthy volunteers and patients to test safety and efficacy. If successful, the company files a New Drug Application with the FDA for approval to market the drug.
This document provides a training report on various analytical instruments used in the pharmaceutical industry. It describes the principles, procedures, calibration methods, acceptance criteria and applications of key instruments like pH meter, balance, Karl Fischer titrator, dissolution test apparatus, UV spectroscopy and HPLC. The report was submitted as part of a B.Tech degree in biotechnology from Jayoti Vidyapeeth Women's University. It includes sections on cleaning, calibration and testing the performance of pH meters, balances and other analytical equipment used at Kusum Healthcare Pvt. Ltd., where the author completed their training.
Drug discovery process style 1 powerpoint presentation templatesSlideTeam.net
The document describes the drug discovery process from preclinical studies through clinical trials to approval. In preclinical studies, a research team is formed, objectives are set, and novel chemicals are synthesized and tested for efficacy and safety in test tubes and animals. Results are used to choose a drug candidate. In clinical trials, the drug is studied in Phase I-III trials with increasing numbers of patients to test safety, efficacy, and get regulatory approval. The company files an Investigational New Drug application and New Drug Application with the FDA.
Strategies for reducing morbidity and mortality from diabetes through healthสปสช นครสวรรค์
This document summarizes recommendations from the Task Force on Community Preventive Services regarding interventions to reduce morbidity and mortality from diabetes. It finds that disease and case management in healthcare systems are strongly recommended for people with diabetes. It also recommends diabetes self-management education in community settings like community centers for adults, and in the home for children and adolescents with type 1 diabetes. There was insufficient evidence to recommend other settings or for adults with type 2 diabetes in the home. The Task Force conducted systematic reviews of interventions focused on healthcare systems and community-based self-management education.
1. The document reports HIV/AIDS statistics for 2556, including 157,000 people living with HIV/AIDS and 3,276.8 new infections.
2. Treatment guidelines are outlined for different CD4 count levels, including the use of viral load monitoring, second line regimens, and laboratory tests.
3. Barriers and recommendations for improving linkage and retention in care are discussed, such as expanding access across different health coverage schemes and centers of excellence.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
This document contains a resume for Arun Kumar, who is seeking a professionally challenging career that allows him to learn and update his skills. He has over 5 years of experience in analytical chemistry and microbiology. His experience includes chemical and microbiological analysis of water, food, and other samples using standardized testing methods. He also has experience in DNA analysis, PCR, and research related to seed and plant development. He holds an MSc in Biotechnology and a BSc in Biotechnology with first class grades.
1) ADICON is a Chinese clinical laboratory company that was established in 2004 and has expanded to include multiple laboratories across China.
2) The document outlines ADICON's history of growth, capacity in various testing areas, quality standards and accreditations, achievements including research collaborations, and vision for the future.
3) ADICON prides itself on high quality services, maintaining various quality standards and accreditations, and has a goal of becoming the top reference clinical laboratory in China and pursuing an IPO by 2013.
S. Lakshmi Narayanan is an analytical research scientist with over 8 years of experience in method validation, development, and analysis in the pharmaceutical industry. He has expertise in GC, HPLC, UV-Vis spectroscopy, dissolution testing, and water content analysis. Narayanan is knowledgeable in GMP and GLP compliance and has experience managing projects and documenting results. He holds an M.Phil. in chemistry and has worked for several companies conducting routine analysis, method development and validation, process optimization, and documentation.
This document provides information about Microcare Laboratory in Surat, India, including its establishment, services, accreditations, staffing, and performance indicators. Microcare Laboratory was established in 2004 and focuses on microbiological and mycobacteriology testing. It has received several accreditations and memberships. Performance data from 2013 shows it processed over 2,000 samples and achieved contamination rates below 5%. Sensitivity and specificity results from a recent external evaluation were over 88%. The laboratory notifies diagnosed TB patients to the local public health authority.
Ch.Rangaih is seeking a position in an organization with strong vision and mission to enhance growth and development. He has a M.Pharmacy from JSS College of Pharmacy with 79.64% and a B.Pharmacy from Nalanda College of Pharmacy with 76.05%. He has over 2 years of work experience as an Assistant Quality Control Officer and Junior Quality Control Chemist. He is proficient in instrumentation skills like HPLC, UV spectroscopy, dissolution testing and has knowledge of quality control and analysis.
Anjireddy Kolla has over 10 years of experience in analytical research and development. He holds an M.Sc. in Organic Chemistry from Andhra University and has worked as an Application Scientist at Thermo Fisher Scientific and Agilent Technologies, providing support on method developments and instrument operation. Currently, he seeks a challenging position utilizing his skills in chromatography, mass spectrometry, method development and validation.
- The document provides a summary of the applicant's work experience over 9 years and 5 jobs in research, R&D, and diagnostic labs for government and private companies.
- The applicant has experience with PCR, real-time PCR, electrophoresis, and other molecular techniques. Key roles included isolating and characterizing biological control agents, developing diagnostic kits, analyzing food and patient samples, and designing primers.
- Educational qualifications include an M.Sc. in Microbiology, B.Sc. in Microbiology/Biochemistry/Food and Nutrition, and current PhD study in Biotechnology. Two research papers have been published.
Mr. Sagar Hasabe is seeking a challenging career in biotechnology utilizing his 8 years of experience in quality control. He currently works as an Assistant Manager in quality control at Loba Chemie Pvt Ltd, a certified ISO company, where he oversees laboratory operations and documentation. Previously he has worked at Nuclear Power Corporation and Nu-Life Pharmaceuticals conducting analytical testing and developing new methods. He has a Master's degree in Biotechnology and is proficient in instruments like HPLC, GC, and UV-Vis spectroscopy.
- The document is a curriculum vitae for Satyanarayana T. that outlines his objective, professional experience, company profile, audits faced, and job profiles from various roles in quality assurance and quality control with pharmaceutical companies.
- He has over 10 years of experience in QA/QC roles at companies including Hetero Labs, Dr. Reddy's Laboratories, Strides Arco Labs, and Aurobindo Pharma.
- His experience includes tasks like analytical testing, audit management, documentation maintenance, and ensuring compliance with cGMP, cGLP, USFDA and other regulatory standards.
The document provides information about the 2012 APHL Annual Meeting & Sixth Government Environmental Laboratory Conference held in Seattle. It includes details about the conference schedule, speakers, workshops hosted by corporate partners, poster sessions, exhibits, and recognition of sustaining members and supporters. Future APHL conferences are also announced.
Good Laboratory Practice (GLP) is a formal set of principles that were established by the FDA in 1978 to ensure the quality and integrity of safety testing data submitted for regulatory purposes. GLP provides guidelines for conducting non-clinical laboratory studies, including requirements for facilities, equipment, personnel responsibilities, quality assurance programs, standard operating procedures, and retention of records and reports. The purpose of GLP is to ensure testing is properly conducted and documented so that results are reliable and can be used to support regulatory decisions.
Good laboratory practices
introduction
reasons behind the creation of glp
Objectives of GLP
The OECD
GLP principles
Test facility organizational and personnel
Quality assurance programme
Facilities
Apparatus, materials and reagents
Test systems
Test and reference items
SOPS- Standard Operating Procedures
Performance of the study
Reporting of the study details
Storage and retention of records and materials
What GLP must contain?
Do this for GLP
Benefits of GLP
Conclusion
The document is a resume for Rosan M. Rivera Vegas summarizing her qualifications for a position in a growing and dynamic organization. She has a Bachelor's Degree in Natural Science from the University of Puerto Rico Bayamon. Her professional experience includes working as a QC Laboratory Technician II and I at Abbvie Biotechnology, Ltd. in Barceloneta, Puerto Rico, where she was responsible for analytical and raw material laboratory testing, small volume parenteral product testing, and verifying laboratory data. She also has skills in Microsoft Office, problem solving, communications, and knowledge of cGMPs, safety regulations, and ISO 9000 standards.
Ammar Al Sabbahen is seeking a stable job in a professional environment. He has a Bachelor's degree in chemical engineering and experience working in laboratories at hospitals and research centers. He has skills operating various instruments like HPLC, GC, and ELISA readers. He also has experience extracting organic compounds, publishing papers, and working on teams.
Micro Therapeutic Research Labs Private Limited is an integrated service provider for pharma and biotech companies. It has facilities across India including in Selaiyur, Coimbatore, Chrompet, and Padi, Chennai. The facilities include clinical pharmacology units, bioanalytical labs, preclinical and biology labs, and are GLP compliant. The company provides services across the drug development spectrum from preclinical research to clinical trials to regulatory submissions. It has experience conducting over 1000 bioavailability and bioequivalence studies for clients globally.
Ghazala Rahim is seeking a quality role that allows her to utilize her expertise in analytical testing and quality control. She has over 15 years of experience in roles of increasing responsibility at pharmaceutical companies. Her experience includes method development and validation, raw material and finished product testing, stability testing, complaint investigation, and ensuring compliance with GMP guidelines. She has strong skills in instrumentation, analytical techniques, method transfers, and training colleagues.
Thiruneelakandan Gnanasambandan is seeking a challenging position in pharmaceuticals, medical devices, healthcare, or biosciences to utilize his skills in product and method development. He has over 5 years of experience in quality control and R&D, specializing in analytical method validation and transfer. He is skilled in HPLC, GC, UV, and titration methods and has experience managing quality teams and ensuring regulatory compliance. His most recent roles include method transfer specialist and quality control head at pharmaceutical companies in Singapore.
Ogundele Olorunfemi has over 10 years of experience in quality control and laboratory analysis. He has worked for various companies analyzing raw materials, products, and effluents to ensure safety and quality standards. He holds an MSc in Chemistry from the University of Lagos and is pursuing further education in Supply Chain Management. He has published several research papers on transition metal complexes and their properties. He is a member of the Chemical Society of Nigeria and has held leadership roles in student organizations. References are available upon request.
This document contains a summary of Mehul D. Patel's work experience and qualifications. It lists his current role as a Research Associate at Torrent Pharmacuticles Ltd since 2006, where he conducts bioanalytical activities and drug metabolism/pharmacokinetics research. Previously he worked as a Research Associate at CADILA Pharmaceutical Ltd from 2005-2006 developing and validating analytical methods. He has a M.Pharm in Pharmacology and B.Pharm degree, and has over 15 years of experience in bioanalytical method development and validation using LC-MS/MS and HPLC techniques.
A newspaper article discusses affordable universal healthcare and progress towards development goals. It notes that in 2015, the UN adopted goals aiming to provide universal healthcare coverage for all citizens worldwide by 2030. Currently, only about half the world's population has access to essential health services.
The document outlines the budget for HIV/AIDS and TB activities in South Africa for the 2022/2023 fiscal year, including funds for testing, treatment, and case management. It details the budgets for various line items such as laboratory services, drugs and supplies, human resources, and district allocations. The budgets are broken down by funding source and program area with specific grant reference numbers provided.
1. The document reports HIV/AIDS statistics for 2556, including 157,000 people living with HIV/AIDS and 3,276.8 new infections.
2. Treatment guidelines are outlined for different CD4 count levels, including the use of viral load monitoring, second line regimens, and laboratory tests.
3. Barriers and recommendations for improving linkage and retention in care are discussed, such as expanding access across different health coverage schemes and centers of excellence.
This document contains data from a study analyzing doses of medication stored at government medical distribution centers (GPOs) and healthcare facilities over a period of 39 weeks. It finds that the percentage of doses available ("on hand") decreased over time, from an average of 87.62% in week 1 to 23.56% by week 39. It also compares the number of doses stored at GPOs to the combined total of doses on hand at GPOs and healthcare facilities, finding the percentage of doses at GPOs decreased from 59.5% to below 50% by week 20. This suggests facilities were withdrawing more doses from GPOs over time to meet demand.
Structural Design Process: Step-by-Step Guide for BuildingsChandresh Chudasama
The structural design process is explained: Follow our step-by-step guide to understand building design intricacies and ensure structural integrity. Learn how to build wonderful buildings with the help of our detailed information. Learn how to create structures with durability and reliability and also gain insights on ways of managing structures.
At Techbox Square, in Singapore, we're not just creative web designers and developers, we're the driving force behind your brand identity. Contact us today.
Company Valuation webinar series - Tuesday, 4 June 2024FelixPerez547899
This session provided an update as to the latest valuation data in the UK and then delved into a discussion on the upcoming election and the impacts on valuation. We finished, as always with a Q&A
Storytelling is an incredibly valuable tool to share data and information. To get the most impact from stories there are a number of key ingredients. These are based on science and human nature. Using these elements in a story you can deliver information impactfully, ensure action and drive change.
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challengesHolger Mueller
Holger Mueller of Constellation Research shares his key takeaways from SAP's Sapphire confernece, held in Orlando, June 3rd till 5th 2024, in the Orange Convention Center.
Zodiac Signs and Food Preferences_ What Your Sign Says About Your Tastemy Pandit
Know what your zodiac sign says about your taste in food! Explore how the 12 zodiac signs influence your culinary preferences with insights from MyPandit. Dive into astrology and flavors!
Implicitly or explicitly all competing businesses employ a strategy to select a mix
of marketing resources. Formulating such competitive strategies fundamentally
involves recognizing relationships between elements of the marketing mix (e.g.,
price and product quality), as well as assessing competitive and market conditions
(i.e., industry structure in the language of economics).
Navigating the world of forex trading can be challenging, especially for beginners. To help you make an informed decision, we have comprehensively compared the best forex brokers in India for 2024. This article, reviewed by Top Forex Brokers Review, will cover featured award winners, the best forex brokers, featured offers, the best copy trading platforms, the best forex brokers for beginners, the best MetaTrader brokers, and recently updated reviews. We will focus on FP Markets, Black Bull, EightCap, IC Markets, and Octa.
The Evolution and Impact of OTT Platforms: A Deep Dive into the Future of Ent...ABHILASH DUTTA
This presentation provides a thorough examination of Over-the-Top (OTT) platforms, focusing on their development and substantial influence on the entertainment industry, with a particular emphasis on the Indian market.We begin with an introduction to OTT platforms, defining them as streaming services that deliver content directly over the internet, bypassing traditional broadcast channels. These platforms offer a variety of content, including movies, TV shows, and original productions, allowing users to access content on-demand across multiple devices.The historical context covers the early days of streaming, starting with Netflix's inception in 1997 as a DVD rental service and its transition to streaming in 2007. The presentation also highlights India's television journey, from the launch of Doordarshan in 1959 to the introduction of Direct-to-Home (DTH) satellite television in 2000, which expanded viewing choices and set the stage for the rise of OTT platforms like Big Flix, Ditto TV, Sony LIV, Hotstar, and Netflix. The business models of OTT platforms are explored in detail. Subscription Video on Demand (SVOD) models, exemplified by Netflix and Amazon Prime Video, offer unlimited content access for a monthly fee. Transactional Video on Demand (TVOD) models, like iTunes and Sky Box Office, allow users to pay for individual pieces of content. Advertising-Based Video on Demand (AVOD) models, such as YouTube and Facebook Watch, provide free content supported by advertisements. Hybrid models combine elements of SVOD and AVOD, offering flexibility to cater to diverse audience preferences.
Content acquisition strategies are also discussed, highlighting the dual approach of purchasing broadcasting rights for existing films and TV shows and investing in original content production. This section underscores the importance of a robust content library in attracting and retaining subscribers.The presentation addresses the challenges faced by OTT platforms, including the unpredictability of content acquisition and audience preferences. It emphasizes the difficulty of balancing content investment with returns in a competitive market, the high costs associated with marketing, and the need for continuous innovation and adaptation to stay relevant.
The impact of OTT platforms on the Bollywood film industry is significant. The competition for viewers has led to a decrease in cinema ticket sales, affecting the revenue of Bollywood films that traditionally rely on theatrical releases. Additionally, OTT platforms now pay less for film rights due to the uncertain success of films in cinemas.
Looking ahead, the future of OTT in India appears promising. The market is expected to grow by 20% annually, reaching a value of ₹1200 billion by the end of the decade. The increasing availability of affordable smartphones and internet access will drive this growth, making OTT platforms a primary source of entertainment for many viewers.
Tata Group Dials Taiwan for Its Chipmaking Ambition in Gujarat’s DholeraAvirahi City Dholera
The Tata Group, a titan of Indian industry, is making waves with its advanced talks with Taiwanese chipmakers Powerchip Semiconductor Manufacturing Corporation (PSMC) and UMC Group. The goal? Establishing a cutting-edge semiconductor fabrication unit (fab) in Dholera, Gujarat. This isn’t just any project; it’s a potential game changer for India’s chipmaking aspirations and a boon for investors seeking promising residential projects in dholera sir.
Visit : https://www.avirahi.com/blog/tata-group-dials-taiwan-for-its-chipmaking-ambition-in-gujarats-dholera/
3 Simple Steps To Buy Verified Payoneer Account In 2024SEOSMMEARTH
Buy Verified Payoneer Account: Quick and Secure Way to Receive Payments
Buy Verified Payoneer Account With 100% secure documents, [ USA, UK, CA ]. Are you looking for a reliable and safe way to receive payments online? Then you need buy verified Payoneer account ! Payoneer is a global payment platform that allows businesses and individuals to send and receive money in over 200 countries.
If You Want To More Information just Contact Now:
Skype: SEOSMMEARTH
Telegram: @seosmmearth
Gmail: seosmmearth@gmail.com
The 10 Most Influential Leaders Guiding Corporate Evolution, 2024.pdfthesiliconleaders
In the recent edition, The 10 Most Influential Leaders Guiding Corporate Evolution, 2024, The Silicon Leaders magazine gladly features Dejan Štancer, President of the Global Chamber of Business Leaders (GCBL), along with other leaders.
The 10 Most Influential Leaders Guiding Corporate Evolution, 2024.pdf
อ้างอิง 3 ngsp list certified lab
1. List of NGSP Certified Laboratories
(updated 7/12, listed by date certified)
The NGSP has certified the following laboratories as having documented traceability to the Diabetes
Control and Complications Trial Reference Method. Laboratories are awarded Certificates of
Traceability for successfully completing bias testing using specific methods, reagent lots, calibrator lots
and instrumentation. The certification criteria for Level II laboratory certification are the same as that
for manufacturers. For Level I laboratories, the certification criteria are more stringent.
Traceability to the DCCT applies only to results from fresh blood samples unless otherwise specified.
Analysis of processed (e.g. lyophilized) material may be subject to matrix effects and any comparisons to
the DCCT using results from processed specimens should be made with caution.
Laboratory Method/s Certification Type Date Certified
Pathcare Klerksdorp, Klerksdorp, South Africa Bio-Rad D-10 Level II Laboratory July, 2012
Bio-Rad Variant II Turbo July, 2012
Pathcare – N1 Reference Lab, Goodwood, South Africa Level II Laboratory
Bio Rad Variant II
Pathcare Port Elizabeth St George, Port Elizabeth, South July, 2012
Bio-Rad D-10 Level II Laboratory
Africa
Pathcare Vereeniging, Vereeniging, South Africa Bio-Rad D-10 Level II Laboratory July, 2012
Pathcare George, George, South Africa Bio-Rad D-10 Level II Laboratory July, 2012
Pathcare East London, East London, South Africa Bio-Rad D-10 Level II Laboratory July, 2012
Shanghai Fenglin Clinical Lab Co. Ltd. Tosoh G7 Level I Laboratory July, 2012
Esoterix Clinical Trials Services, Mechelen, Belgium Roche Integra 400 Level II Laboratory July, 2012
LabCorp Clinical Tirals, Cranford, NJ Roche Integra 400 Level II Laboratory July, 2012
Demolab Roche-Bogota Colombia Roche Cobas c501 Level II Laboratory July, 2012
PPC Central Laboratory, Teipei, Taiwan Bio Rad Variant II Level I Laboratory July, 2012
Clinigene Central Laboratory, Bangalore, India Bio-Rad D-10 Level II Laboratory July, 2012
Clinical Reference Laboratory – Gen Lab, Lenexa, KS Roche Cobas Integra 800 CTS Level I Laboratory July, 2012
Medpace Reference Laboratories, Cincinnati, OH Tosoh G8 Level I Laboratory July, 2012
Kingmed Center for Clinical Laboratory, Guangzhou,
Bio-Rad D-10 Level I Laboratory June, 2012
China
Quintiles Technologies Private Limited, Mumbai, India Bio-Rad D-10 Level I Laboratory June, 2012
Clinical Trial Testing Laboratory, Mitsubishi Chemical
Bio-Rad D-10 Level I Laboratory June, 2012
Medience Corporation, Tokyo, Japan
Quintiles Lab South Africa, Centurion, South Africa Bio-Rad D-10 Level I Laboratory June, 2012
PPD Global Central Labs - Europe, Brussels, Belgium Tosoh G8 Level I Laboratory June, 2012
Eurofins Technology Services (Suzhou) Co Ltd,
Bio-Rad Variant II Level I Laboratory June, 2012
Shanghai, China
Eurofins Medinet Pte Ltd., Singapore Bio-Rad Variant II Level I Laboratory June, 2012
Department of Laboratory Medicine, Zhongshan Hospital,
Bio Rad Variant II Level I Laboratory May, 2012
Fudan University, Shanghai, P.R. China
Quest Diagnostics Clinical Trials Singapore (Tan Tock
Bio-Rad D-10 Level I Laboratory May, 2012
Seng Hospital), Singapore
Laboratorio De. Patologia Clinica Medica Sur, Deleg.
Bio-Rad D-10 Level I Laboratory May, 2012
Tlalpan C.P., Mexico
MLM Medical Labs, Moenchengladbach, Germany Tosoh G8 Level I Laboratory May, 2012
Lambda Therapeutic Research, Ahmedabad, India Bio-Rad D-10 Level I Laboratory May, 2012
Super Religare Laboratories Limited, Mumbai, India Bio-Rad D-10 Level I Laboratory May, 2012
Southern.IML Pathology, Wollongong NSW, Australia Bio-Rad VII Turbo 2.0 Level I Laboratory May, 2012
Mayo Medical Laboratories New England, Andover, MA Bio-Rad Variant II Level I Laboratory May, 2012
ICON Central Laboratory – India, Bangalore, India Bio-Rad Variant II Level I Laboratory May, 2012
Bayer A1cNOW+, Sunnyvale, CA Tosoh G7 Level II Laboratory May, 2012
PPD Global Central Labs, Highland Heights, KY Tosoh G8 Level I Laboratory May, 2012
Eurofins Medinet BV, Breda, The Netherlands Bio-Rad Variant II Level I Laboratory May, 2012
SRL, Inc., Kanagawa, Japan Arkray HA-8160 Level I Laboratory May, 2012
2. List of NGSP Certified Laboratories (updated 07/12, listed by date certified)
Laboratory Method/s Certification Type Date Certified
Bio-Rad VII Turbo
Quintiles Laboratories Ltd., Marietta, GA Level I Laboratory April, 2012
(10504, 10522)
ICON Central Laboratories, Dublin, Ireland Bio-Rad Variant II Level I Laboratory April, 2012
Grupo Diagnostico Medico Proa S.A. de C.V., Colonia
Bio-Rad Variant II Turbo Level I Laboratory April, 2012
San Rafael CP, Mexico
Quest Diagnostics India, Pvt. Ltd., Haryana, India Bio-Rad Variant II Level I Laboratory April, 2012
Quest Kingmed Alliance Lab, Shanghai, China Tosoh G8 Level I Laboratory April, 2012
Quest Diagnostics Clinical Trials Laboratory, Heston, UK Tosoh G8 Level I Laboratory April, 2012
Quest Diagnostics Clinical Trials Laboratory, Valencia,
Tosoh G8 Level I Laboratory April, 2012
CA
Bio-Rad Variant II Turbo
Clearstone Central Laboratories, Beijing, China Level I Laboratory April, 2012
2.0
LabCorp Clinical Trials – Cranford Laboratory, Cranford, Bio-Rad Variant II Turbo
Level I Laboratory April, 2012
NJ 2.0
Bio-Rad Variant II Turbo
Clearstone Central Laboratories, Singapore Level I Laboratory April, 2012
2.0
Kotobiken Medical Laboratories, Inc. Biken Central Kyowa Medex Determiner
Level II Laboratory March, 2012
Laboratory Tsukuba, Tsukuba-shi, Ibaraki, Japan HbA1c on JCA-BM9130
Kotobiken Medical Laboratories, Inc., Niigata
Tosoh G8 Level II Laboratory March, 2012
Laboratory, Niigata City, Japan
Siemens Dimension
Barnes Jewish Hospital, St. Louis, MO Level I Laboratory March, 2012
RxL/MAX
Department of Endocrinology PUMC Hospital, Beijing,
Bio-Rad Variant II Turbo Level I Laboratory March, 2012
China
Bio-Rad Variant II Turbo
Green Cross Reference Laboratory, Yongin City, Korea Level I Laboratory March, 2012
2.0
Eurofins Medinet Inc., Chantilly, VA Bio-Rad Variant II Level I Laboratory March, 2012
Bio-Rad Variant II Turbo
Quintiles Laboratories Japan, Tokyo, Japan Level I Laboratory March, 2012
2.0
Medpace Reference Laboratories BVBA, Leuven,
Tosoh G7 Level I Laboratory March, 2012
Belgium
ACM Medical Laboratory, Inc., Rochester, NY Tosoh G7 Level I Laboratory March, 2012
Seoul Clinical Laboratories Central Lab, Seoul, South
Roche Cobas Integra 400 Level I Laboratory February, 2012
Korea
Laboratorio Hidalgo, Buenos Aires, Argentina Bio-Rad Variant II Turbo Level I Laboratory February, 2012
Clinical Reference Laboratory EU-Ltd, Cambridge, UK Bio-Rad Variant II Level I Laboratory February, 2012
B.A.R.C. (Bio Analytical Research Corp), Ghent,
Menarini HA-8160 Level I Laboratory February, 2012
Belgium
PathCare Clinical Trials, Goodwood, South Africa Bio-Rad D-10 Level I Laboratory February, 2012
Quintiles Laboratories Singapore Bio-Rad Variant II Level I Laboratory February, 2012
Union Clinical Laboratory, Taipei, Taiwan Tosoh G8 Level I Laboratory January, 2012
Far Eastern Memorial Hospital, New Taipei City, Taiwan Tosoh G8 Level I Laboratory January, 2012
ACM Global Central Laboratory, York, UK Tosoh G7 Level I Laboratory January, 2012
DASA, Barueri, Brazil Bio-Rad VII Turbo Level I Laboratory January, 2012
Cirion BioPharma Research, Inc., Laval, Canada Bio-Rad Variant Level I Laboratory January, 2012
Clinical Reference Laboratory, Lenexa, KS Bio-Rad Variant II Level I Laboratory January, 2012
Bio-Rad D-10
Quintiles China, Beijing, China Level I Laboratory January, 2012
Bio-Rad Variant II
Medpace Reference Laboratories, Beijing, China Tosoh G7 Level I Laboratory January, 2012
Asociación Colombiana de Diabetes, Bogotá, DC.
Bio-Rad D-10 Level II Laboratory December, 2011
Colombia
Centro Médico Imbanaco de Cali , Calí, Colombia Bio-Rad D-10 Level II Laboratory December, 2011
Coomeva Medicina Prepagada, Medellín, Colombia Bio-Rad D-10 Level II Laboratory December, 2011
Empresa Social del Estado Metrosalud, Medellín,
Bio-Rad Variant II Level II Laboratory December, 2011
Colombia
Laboratorio Clínico Hospital Central de la Policía,
Bio-Rad Variant II Turbo Level II Laboratory December, 2011
Bogotá, DC. Colombia
2
3. List of NGSP Certified Laboratories (updated 07/12, listed by date certified)
Laboratory Method/s Certification Type Date Certified
Laboratorio Médico Las Américas, Medellín, Colombia Bio-Rad D-10 Level II Laboratory December, 2011
Laboratorio Clínico Médico Colcan, Bogota, DC.
Bio-Rad Variant II Level II Laboratory December, 2011
Colombia
Laboratorio de Investigación Hormonal, Bogota, DC.
Bio-Rad D-10 Level II Laboratory December, 2011
Colombia
Shanghai D.A. Medical Testing Center Co. Ltd.,
Tosoh G7 Level I Laboratory December, 2011
Shanghai, China
Health Sciences Research Institute East Japan, Saitama-
Tosoh G7 Level I Laboratory December, 2011
Pref, Japan
Gribbles Pathology (M) SDN.BHD., Selangor, Malaysia Roche Cobas Integra 800 Level II Laboratory December, 2011
Union Clinical Laboratory, Taipei, Taiwan Bio-Rad Variant II Turbo Level I Laboratory December, 2011
Quintiles Technologies (I) Private Ltd., Mumbai, India Bio-Rad Variant II Level I Laboratory December, 2011
Bio-Rad Variant II
Clinical Research and Clinical Trials Laboratory,
HbA2/HbA1c Dual Level I Laboratory December, 2011
Hamilton, Canada
WB & DBS collection
Laboratorio Clinico Hematologico, Medellin, Colombia Tosoh G7 Level I Laboratory December, 2011
Medpace Reference Laboratories, Mumbai, India Tosoh G7 Level I Laboratory December, 2011
Roche Cobas Integra 800
Heritage Labs International, LLC, Olathe, KS Level I Laboratory December, 2011
CTS
LifeLabs, Toronto, Canada Roche Cobas Integra 800 Level I Laboratory December, 2011
Super Religare Laboratories Limited, Mumbai, India Bio-Rad Variant II Level I Laboratory December, 2011
Diagnosearch Life Sciences Pvt Ltd, Mumbai, India Bio-Rad D-10 Level I Laboratory December, 2011
Northwest Lipid Metabolism and Diabetes Research
Tosoh G8 Level I Laboratory December, 2011
Laboratories, Seattle, WA
Laboratorio De Nutricion, Diabetes Y Metabolismo,
Bio-Rad Variant II Level II Laboratory November, 2011
Santiago Centro, Chile
North Shore LIJ Health System Laboratories, Lake
Tosoh G8 Level I Laboratory November, 2011
Success, NY
Endocrine Research Lab, Kyung Hee University, Seoul,
Tosoh G7 Level II Laboratory November, 2011
Korea
Celerion, Lincoln, NE Cobas 6000 Level II Laboratory November, 2011
BARC SA, Gauteng, South Africa Bio-Rad D-10 Level I Laboratory November, 2011
B.M.L. Kawagoe Laboratory, Saitama, Japan Tosoh G7 Level I Laboratory November, 2011
Bio-Rad Variant II
Centralab, Buenos Aires, Argentina Level I Laboratory November, 2011
Bio-Rad D-10
Lancet Laboratories – Kwazulu Natal, S. Africa Bio-Rad Variant II Level II Laboratory November, 2011
Lancet Laboratories – Pencardia, S. Africa Bio-Rad Variant II Level II Laboratory November, 2011
Lancet Laboratories – Johannesburg, S. Africa Bio-Rad Variant II Level II Laboratory November, 2011
Home Access Health Corporation, Hoffman Estates, IL Olympus Au640e Level II Laboratory November, 2011
Metropolis Healthcare Ltd, Mumbai, India Bio-Rad D-10 Level I Laboratory November, 2011
ICON Central Laboratories, Farmingdale, NY Bio-Rad Variant II Level I Laboratory November, 2011
Clearstone Central Laboratories, Singapore Bio-Rad Variant II Level I Laboratory November, 2011
Quintiles Laboratories Europe, Livingston, West Lothian,
Bio-Rad VII Turbo Level I Laboratory November, 2011
Scotland, UK
Prodia Clinical Laboratory, Jakarta Pusat, Indonesia Bio-Rad Variant II Level I Laboratory October, 2011
PathLab Medical laboratories Ltd, Hong Kong, China Bio-Rad D-10 Level II Laboratory October, 2011
Beijing Lawke Health Lab, Beijing, China Tosoh G7 Level I Laboratory October, 2011
Esoterix Clinical Trials Services, A Division of Labcorp,
Bio-Rad Variant II Level I Laboratory October, 2011
Cranford, NJ
Shanghai Diabetes Institute, Shanghai Jiaotong Univeristy
Bio-Rad VII Turbo Level I Laboratory October, 2011
No.6 People’s Hospital, Shanghai, China
Eurofins Pharma Services India Pvt Ltd, Bangalore, India Bio-Rad Variant II Level I Laboratory October, 2011
Quest Diagnostics, Nichols Institute, Chantilly, VA Roche Cobas Integra 800 Level II Laboratory October, 2011
Spectra East, Rockleigh, NJ Roche Cobas Integra 800 Level I Laboratory October, 2011
Samkwang Medical Laboratories, Seoul, Korea Roche Cobas Integra 800 Level I Laboratory October, 2011
Neodin Medical Institute, Seoul, South Korea Tosoh G8 Level I Laboratory October, 2011
Sonic Clinical Trials, Macquarie Park, NSW, Australia Bio-Rad D-10 Level I Laboratory October, 2011
3
4. List of NGSP Certified Laboratories (updated 07/12, listed by date certified)
Laboratory Method/s Certification Type Date Certified
Eone Medical Foundation, Seoul, Korea Roche Cobas Integra 800 Level I Laboratory October, 2011
ACT Pathology, Woden, Australia Bio-Rad Variant II Turbo Level I Laboratory September, 2011
Adicon Clinical Laboratory, Shanghai, China Bio-Rad Variant II Level I Laboratory September, 2011
Dorevitch Pathology Clinical Trials, Heidelberg, Australia Bio-Rad Variant II Level I Laboratory September, 2011
Laboratory of Endocrinology, Chinese PLA General
Bio-Rad Variant II Level I Laboratory September, 2011
Hospital, Beijing, China
CB Laboratory, Saitama, Japan Bio-Rad VII Turbo 2.0 Level I Laboratory September, 2011
Covance Central Laboratory, Shanghai, China Bio-Rad Variant II Level I Laboratory September, 2011
PPD Global Central Laboratories, Singapore Tosoh G7 Level I Laboratory September, 2011
Quest Diagnostics, Nichols Institute, San Juan Capistrano,
Roche Cobas Integra 800 Level II Laboratory September, 2011
California
Covance Central Laboratory, Geneva, Switzerland Bio-Rad VII Turbo Level I Laboratory September, 2011
Covance Asia Pte Ltd, Singapore Bio-Rad Variant II Level I Laboratory September, 2011
Covance CLS US, Indianapolis, IN Bio-Rad Variant II Turbo Level I Laboratory September, 2011
Department of Laboratory Medicine, Huashan Hospital, Bio-Rad Variant II
Level I Laboratory September, 2011
Shanghai, China Tosoh G7
ICON-Singapore, Singapore Bio-Rad Variant II Level I Laboratory August, 2011
National University Hospital, Singapore Bio-Rad Variant II Level I Laboratory August, 2011
Northshore -LIJ Core Laboratory, Lake Success, NY Tosoh G7 Level I Laboratory August, 2011
LKF-Laboratorium fuer Klinische Forschung,
Roche Modular P800 Level I Laboratory August, 2011
Schwentinental, Germany
ICON Central Laboratories – China, Tianjin, China Bio-Rad Variant II Level I Laboratory August, 2011
4